maaf email atau password anda salah

Satu Akun, Untuk Semua Akses

Forgot Password ? Click Here

atau Masuk melalui

Google

Belum Memiliki Akun Daftar di Sini

Satu Akun, Untuk Semua Akses


Have an account? Log in here

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Satu Akun, Untuk Semua Akses

Enter your email, untuk mereset password

Konfirmasi Email

Kami telah mengirimkan link reset password melalui email ke rudihamdani@gmail.com.

Ubah No. Telepon

Ubah Password

Topik Favorit

Hapus Berita

Apakah Anda yakin akan menghapus berita?

Ubah Data Diri

Jenis Kelamin

Other Tempo Media
Majalah Tempo
Koran Tempo
Tempo.co
Subscribe

We’ve Exercised Maximum Oversight

Monday, 31 October 2022

BPOM Chief Penny Lukito responds to the allegation that her agency has been slow in handling acute kidney injury cases.

Food and Drugs Monitoring Agency Chief Penny K. Lukito during a press conference about the control of syrup medicines indicated as the cause of acute kidney injury in children at the BPOM office, Jakarta, October 23. TEMPO/Febri Angga Palguna . tempo : 168605687724_

THE recent cases of acute kidney injuries in children have thrown spotlight on the performance of the Food and Drug Monitoring Agency (BPOM). The agency headed by Penny Lukito has been criticized for failing to effectively monitor the safety of the drugs in the market. As of last Thursday, October 24, a total of 269 acute kidney injury cases have been recorded, including 157 deaths.

Penny asserted that BPOM had handled the cases optimally adding

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine
Subscribe

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card
Subscribe

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

Egi Adyatama

interview Penny Lukito BPOM Acute Kidney Failures Children Kidney Failures Acute Kidney Injury Pharmaceutical Industry

Newsletter

Get daily summary of exclusive and in-depth news in your email Inbox by joining the Newsletter

Prev Next

More Articles

More exclusive contents

  • June 5, 2023

  • May 29, 2023

  • May 22, 2023

  • May 15, 2023

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe